Abstract:OBJECTIVE:The aim of this study was to evaluate the potential efficacy of therapy with thymosin alpha(1) and ulinastatin for patients with sepsis due to carbapenem-resistant bacteria.DESIGN:Prospective, randomized, parallel controlled clinical study.METHODS:A total of 120 patients received a diagnosis of sepsis caused by infection with carbapenem-resistant bacteria and satisfied the study enrollment criteria. Sixty patients received carbapenems combined with thymosin alpha(1) and ulinastatin (the CTU group), and the other 60 patients were treated with carbapenems and placebo (the CP group). For both groups, flow cytometry was used to enumerate lymphocyte subsets, and ELISA was used to determine cytokine concentrations.RESULTS:When the 2 groups were compared, the CTU group exhibited a better performance with respect to organ failure scores such as the Acute Physiology and Chronic Health Evaluation II score, the Multiple Organ Failure Score, and the Glasgow Coma Scale. The CTU group also showed significant improvements in CD4(+)CD8(+) count after initiation of treatment. In addition, compared with the CP group, in the CTU group the balance between proinflammatory mediators (such as tumor necrosis factor-alpha, interleukin [IL]-1beta, IL-6, and IL-8) and anti-inflammatory cytokines (including IL-4 and IL-10) was better modulated, and the cumulative survival rate of the CTU group exceeded that of the CP group by 17.8% at day 28, 25.9% at day 60, and 27.4% at day 90.CONCLUSION:Immunomodulatory therapy that combines thymosin alpha(1) and ulinastatin appears to improve the survival rate for patients infected with carbapenem-resistant bacteria. The number of patients in this study was relatively small, and although the same number of patients was initially enrolled in each study group, the groups were not the same size at the end of the study. Therefore, a larger clinical trial should be conducted to validate this conclusion.TRIAL REGISTRATION:The trial was registered with the Chinese State Food and Drug Administration (Peking Science and Technology Development Plan, 2002[641]), (registration number 2007Y0211).

An experimental study of metabolic intervention of antiTNF antibody in intraabdominal infection complicated by multiple organ dysfunction syndrome

The Role of Anti-Tumor Necrosis Factor Antibody in the Treatment of Multiple Organ Dysfunction Syndrome Induced by Intra-Abdominal Infection

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Effects of Baicalin and Octreotide on the Serum TNF-α Level and Apoptosis in Multiple Organs of Rats with Severe Acute Pancreatitis

[The Effects of Removing Circulated TNF by Immunoadsorption on Renal Changes in Rabbits with Endotoxin Shock].

Experimental Research on the Effects of a Traditional Chinese Medicine Complex 912 for Injection on Serum Cytokine Levels in the Multiple Organ Dysfunction Syndrome Animal Model

Thymosin Alpha(1)- and Ulinastatin-Based Immunomodulatory Strategy for Sepsis Arising from Intra-Abdominal Infection Due to Carbapenem-Resistant Bacteria

Intervention studies of endotoxemia in acute liver failure rats

IFN-τ Alleviates Lipopolysaccharide-Induced Inflammation by Suppressing NF-κB and MAPKs Pathway Activation in Mice

The Therapeutic Effect of an Anti-TNF-α/HSA/IL-6R Triple-Specific Fusion Protein Under Experimental Septic Conditions

Experimental study of liver injury in rats of abdominal infection with abdominal compartment syndrome

Changes of Cytokines in the Multiple Organ Dysfunction Syndrome in Animals

Influences of Enteral Nutrition Combined with TCM Intervention on Inflammation and Intestinal Barrier Function in Severe Acute Pancreatitis in Rabbits

Anti-tumor necrosis factor-α monoclonal antibody alleviates parenteral nutrition-associated liver disease in mice.

[Effect of Thymosin Alpha1 on Immunological Function and Metabolism in Peritoneal Sepsis Rats].

Effect of bio-artificial renal tubule on cytokine level and survival time in porcine models

The Effect of Monoclonal Antibody of Tumor Necrosis Factor-Α and Glutathione on Rat Fat Liver Experimental Models

Treatment of experimental autoimmune uveoretinitis with anti-tumor necrosis factor-α monoclonal antibody

Characteristics of TNFa and Its Effects on Organ Function During Infection Stage in Severe Acute Pancreatitis

Experimental study on anti-TNF-alpha monoclonal antibody attenuating skeletal muscle ischemia reperfusion injury

Metabolic Changes at the Early Stage of Sepsis Induced by Cecal Ligation and Puncture in Rats and the Interventional Effects of Huang-Lian-Jie-Du-Tang